3,220 Shares in Cognex Co. (NASDAQ:CGNX) Purchased by R Squared Ltd

R Squared Ltd purchased a new stake in Cognex Co. (NASDAQ:CGNXFree Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 3,220 shares of the scientific and technical instruments company’s stock, valued at approximately $115,000.

Other large investors also recently made changes to their positions in the company. Impax Asset Management Group plc lifted its stake in Cognex by 2.6% during the third quarter. Impax Asset Management Group plc now owns 5,230,271 shares of the scientific and technical instruments company’s stock valued at $211,303,000 after purchasing an additional 131,560 shares during the last quarter. State Street Corp boosted its stake in shares of Cognex by 0.8% during the 3rd quarter. State Street Corp now owns 5,190,365 shares of the scientific and technical instruments company’s stock worth $210,210,000 after acquiring an additional 42,882 shares in the last quarter. Disciplined Growth Investors Inc. MN raised its position in shares of Cognex by 8.9% during the third quarter. Disciplined Growth Investors Inc. MN now owns 3,751,807 shares of the scientific and technical instruments company’s stock worth $151,948,000 after purchasing an additional 305,913 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Cognex by 5.1% during the third quarter. Geode Capital Management LLC now owns 3,608,028 shares of the scientific and technical instruments company’s stock valued at $146,157,000 after purchasing an additional 175,423 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its position in shares of Cognex by 122.7% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,834,755 shares of the scientific and technical instruments company’s stock valued at $114,808,000 after purchasing an additional 1,562,115 shares during the period. Institutional investors own 88.12% of the company’s stock.

Insider Activity at Cognex

In other news, CTO Joerg Kuechen sold 2,934 shares of the business’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $37.75, for a total value of $110,758.50. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Anthony Sun sold 26,000 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $40.03, for a total transaction of $1,040,780.00. Following the sale, the director now owns 26,608 shares of the company’s stock, valued at $1,065,118.24. This trade represents a 49.42 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Cognex Trading Up 1.3 %

NASDAQ CGNX opened at $39.72 on Friday. Cognex Co. has a 1 year low of $34.79 and a 1 year high of $53.13. The company has a fifty day simple moving average of $38.15 and a 200 day simple moving average of $40.02. The company has a market cap of $6.81 billion, a P/E ratio of 76.39 and a beta of 1.40.

Analyst Upgrades and Downgrades

CGNX has been the subject of a number of analyst reports. Truist Financial upped their price objective on shares of Cognex from $42.00 to $43.00 and gave the company a “hold” rating in a research note on Thursday, January 16th. Needham & Company LLC lowered their price objective on shares of Cognex from $50.00 to $47.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Stephens reaffirmed an “overweight” rating and issued a $55.00 target price on shares of Cognex in a research report on Thursday, January 2nd. Cantor Fitzgerald upgraded Cognex to a “strong-buy” rating in a report on Friday, December 20th. Finally, Citigroup decreased their price objective on Cognex from $44.00 to $42.00 and set a “neutral” rating for the company in a research report on Monday, January 13th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Cognex has an average rating of “Moderate Buy” and an average target price of $47.92.

Read Our Latest Analysis on CGNX

About Cognex

(Free Report)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Read More

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.